Pharmaceutical Science 2 (11615.1)
Please note these are the 2023 details for this unit
| Available teaching periods | Delivery mode | Location |
|---|---|---|
| View teaching periods | On-Campus |
UC - Canberra, Bruce |
| EFTSL | Credit points | Faculty |
| 0.125 | 3 | Faculty Of Health |
| Discipline | Study level | HECS Bands |
| Discipline Of Pharmacy | Level 2 - Undergraduate Intermediate Unit | Band 2 2021 (Commenced After 1 Jan 2021) Band 3 2021 (Commenced Before 1 Jan 2021) |
This unit investigates the fundamental concepts of drug stability, new drug registration, biopharmaceutics, and bioequivalence. It also undertakes a detailed investigation of various drug delivery systems and complex dosage forms utilised in modern medicine.
1. Summarise the key principles of drug stability, drug discovery, and regulation of new drugs into the market;
2. Justify the purpose and choice of advanced medicine types or formulation systems with reference to clinical outcomes for the patient; and
3. Integrate key patient, drug and/or dosage form related factors that influence bioavailability and apply these to the concept of bioequivalence and other relevant clinical scenarios.
1. UC graduates are professional - use creativity, critical thinking, analysis and research skills to solve theoretical and real-world problems
2. UC graduates are global citizens - make creative use of technology in their learning and professional lives
2. UC graduates are global citizens - think globally about issues in their profession
2. UC graduates are global citizens - understand issues in their profession from the perspective of other cultures
3. UC graduates are lifelong learners - evaluate and adopt new technology
Learning outcomes
On successful completion of this unit, students will be able to:1. Summarise the key principles of drug stability, drug discovery, and regulation of new drugs into the market;
2. Justify the purpose and choice of advanced medicine types or formulation systems with reference to clinical outcomes for the patient; and
3. Integrate key patient, drug and/or dosage form related factors that influence bioavailability and apply these to the concept of bioequivalence and other relevant clinical scenarios.
Graduate attributes
1. UC graduates are professional - employ up-to-date and relevant knowledge and skills1. UC graduates are professional - use creativity, critical thinking, analysis and research skills to solve theoretical and real-world problems
2. UC graduates are global citizens - make creative use of technology in their learning and professional lives
2. UC graduates are global citizens - think globally about issues in their profession
2. UC graduates are global citizens - understand issues in their profession from the perspective of other cultures
3. UC graduates are lifelong learners - evaluate and adopt new technology
Prerequisites
10288 Pathology, Immunology and Microbiology AND 11614 Pharmaceutical Science 1 AND 6530 Biochemistry.Corequisites
None.Incompatible units
None.Equivalent units
None.Assumed knowledge
None.
Availability for enrolment in 2023 is subject to change and may not be confirmed until closer to the teaching start date.
| Year | Location | Teaching period | Teaching start date | Delivery mode | Unit convener |
|---|---|---|---|---|---|
| 2022 | UC - Canberra, Bruce | Semester 2 | 01 August 2022 | On-Campus | Dr Zahid Hussain |
| 2023 | UC - Canberra, Bruce | Semester 2 | 31 July 2023 | On-Campus | Dr Zahid Hussain |
The information provided should be used as a guide only. Timetables may not be finalised until week 2 of the teaching period and are subject to change. Search for the unit
timetable.
